top of page
FDA Approves First-of-its-Kind Noninvasive Focused Ultrasound Device for Low Back Pain
https://www.linkedin.com/posts/fusfoundation_fda-approves-first-of-its-kind-noninvasive-activity-7396570496546271232-Bv8G/

Shared FUSMobile
Dec 10, 2025


Neurolyser XR Now FDA Cleared for Sale in USA.
For more details: https://fox4kc.com/business/press-releases/ein-presswire/867980694/neurolyser-xr-now-fda-cleared-for-sale-in-usa/

Shared FUSMobile
Nov 21, 2025


Tech Alpharetta’s Latest Graduate Looks To Non-Invasively Treat Back Pain
For more details: https://hypepotamus.com/companies/fusmobile-feature/

Shared FUSMobile
Nov 21, 2025


Sault Area Hospital introducing non-invasive pain treatment technology
For more details: https://www.sootoday.com/local-news/sault-area-hospital-introduces-non-invasive-pain-treatment-technology-11512101 And a video here: https://www.youtube.com/watch?v=XmZBjaInS4k

Shared FUSMobile
Nov 21, 2025


Focused Ultrasound for Low Back Pain: First-of-Its-Kind Device Receives FDA Clearance
For more details: https://www.fusfoundation.org/posts/focused-ultrasound-for-low-back-pain-first-of-its-kind-device-receives-fda-clearance

Shared FUSMobile
Nov 20, 2025


Sault Area Hospital Launches Neurolyser XR HIFU for Non-Invasive Pain Management
For more information please see link below https://sah.on.ca/press/news/sault-area-hospital-launches-neurolyser-xr-hifu-for-non-invasive-pain-management/

Shared FUSMobile
Nov 19, 2025


Neurolyser XR Now FDA Cleared for Sale in USA.
Revolutionary Non-invasive Needleless Procedure for Treating Low Back Pain ALPHARETTA, GA, UNITED STATES, November 17, 2025 / EINPresswire.com / -- FUSMobile , Inc. is proud to announce that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for the non-invasive treatment of low back pain. The Neurolyser XR is a first-of-its-kind device that uses high-intensity focused ultrasound (HIFU) to non-invasiv

Shared FUSMobile
Nov 17, 2025


Unika Medical Centre Becomes First in North America to Offer Non-Invasive BackPain Treatment with Neurolyser XR
FUSMobile, Inc. is proud to announce that Unika Medical Centre, in collaboration with the Premier Pain Institute of Toronto, has become the first clinical site in North America to commercially implement the Neurolyser XR system for the non-invasive treatment of low back pain. Under the leadership of Dr. Gofeld, Unika Medical Centre has transitioned from a key clinical research site to the first commercial provider of this cutting-edge technology. The Neurolyser XR is a first-

Shared FUSMobile
Jun 25, 2025



Shared FUSMobile
Oct 23, 2024


The Neurolyser Was Granted CE Mark
FUSMobile has announced that its Neurolyser XR device has been granted CE Mark for the treatment of lumbar zygapophyseal joints...

Shared FUSMobile
Oct 18, 2024


Sacroiliitis study opens in UVA
The first few participants have been enrolled in a new clinical trial investigating the safety and efficacy of using FUSMobile’s...

Shared FUSMobile
Oct 18, 2024


Company Profile: FUSMobile
In 2014, FUSMobile co-founders Arik Hananel, MD, and Ron Aginsky, LLB, MBA, identified a need for a compact, mobile, and user-friendly...

Shared FUSMobile
Jun 18, 2024
bottom of page
